股本结构
单位：万股
| 公告日期 | 2025-11-10 | 2025-11-10 | 2025-08-07 | 2025-08-07 | 2025-05-08 | 2025-05-08 |
|---|---|---|---|---|---|---|
| 证券总股本 | 6644.95 | 6644.68 | 6640.65 | 6639.42 | 6639.42 | 6638.42 |
| 普通股本 | 6644.95 | 6644.68 | 6640.65 | 6639.42 | 6639.42 | 6638.42 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-10-29 | 2025-09-30 | 2025-07-28 | 2025-06-30 | 2025-04-30 | 2025-03-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-11-10 | 6644.95 | 未披露 | 定期报告 | 2025-10-29 |
| 2025-11-10 | 6644.68 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Shares issued under stock option and employee stock purchase plans
|
2025-09-30 |
| 2025-08-07 | 6640.65 | 未披露 | 定期报告 | 2025-07-28 |
| 2025-08-07 | 6639.42 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Shares issued under stock option and employee stock purchase plans
|
2025-06-30 |
| 2025-05-08 | 6639.42 | 未披露 | 定期报告 | 2025-04-30 |
| 2025-05-08 | 6638.42 | 未披露 |
更多>>
From December 31, 2024 to March 31, 2025
Shares issued under stock option and employee stock purchase plans
|
2025-03-31 |
| 2025-02-27 | 6638.38 | 未披露 | 定期报告 | 2025-02-14 |
| 2025-02-27 | 6637.45 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Shares issued under stock option and employee stock purchase plans
Shares issued in underwritten offering, net
|
2024-12-31 |
| 2024-11-06 | 6634.42 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Shares issued under stock option and employee stock purchase plans
|
2024-09-30 |
| 2024-08-08 | 6628.76 | 未披露 | 定期报告 | 2024-07-31 |
| 2024-08-08 | 6628.07 | 未披露 |
更多>>
From March 31, 2024 to June 30, 2024
Shares issued under stock option and employee stock purchase plans
|
2024-06-30 |
| 2024-05-06 | 6591.05 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Shares issued under stock option and employee stock purchase plans
Shares issued in underwritten offering, net
|
2024-03-31 |
| 2024-03-01 | 6442.07 | 未披露 |
更多>>
Common stock offered 8,520,000 shares by the company
|
2024-03-05 |
| 2024-02-26 | 5590.07 | 未披露 | 定期报告 | 2024-02-14 |
| 2024-02-26 | 5588.34 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Shares issued in underwritten offering, net
Shares issued under stock option and employee stock purchase plans
|
2023-12-31 |
| 2023-11-08 | 5468.92 | 未披露 |
更多>>
Common stock offered 7,425,000 shares by the company
|
2023-11-10 |
| 2023-11-02 | 4726.42 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Shares issued under stock option and employee stock purchase plans
|
2023-09-30 |
| 2023-08-08 | 4726.08 | 未披露 | 定期报告 | 2023-07-31 |
| 2023-04-25 | 4725.25 | 未披露 | 定期报告 | 2023-04-18 |
| 2023-04-25 | 4725.19 | 未披露 | 定期报告 | 2023-04-05 |
| 2023-05-04 | 4724.47 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Shares issued under stock option and employee stock purchase plans
|
2023-03-31 |
| 2023-02-28 | 4720.72 | 未披露 | 定期报告 | 2023-02-13 |
| 2023-02-28 | 4720.07 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Shares issued under stock option and employee stock purchase plans
|
2022-12-31 |
| 2022-11-09 | 4709.98 | 未披露 | 定期报告 | 2022-10-31 |
| 2022-11-09 | 4709.61 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Shares issued under stock option and employee stock purchase plans
|
2022-09-30 |
| 2022-08-08 | 4677.24 | 未披露 | 定期报告 | 2022-07-29 |
| 2022-08-08 | 4676.47 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Shares issued under stock option and employee stock purchase plans
|
2022-06-30 |
| 2022-05-05 | 4675.43 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Shares issued under stock option and employee stock purchase plans
|
2022-03-31 |
| 2022-02-28 | 4673.50 | 未披露 | 定期报告 | 2022-02-17 |
| 2022-02-28 | 4673.02 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Shares issued under stock option and employee stock purchase plans
Shares issued in underwritten offering, net
|
2021-12-31 |
| 2021-11-09 | 4666.39 | 未披露 | 定期报告 | 2021-10-31 |
| 2021-11-09 | 4666.33 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Shares issued under stock option and employee stock purchase plans
Shares issued in underwritten offering, net
|
2021-09-30 |
| 2021-08-05 | 4648.18 | 未披露 | 定期报告 | 2021-07-31 |
| 2021-07-16 | 4556.70 | 未披露 |
更多>>
1.Common stock offered 5,952,381 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 39,614,638 shares of common stock outstanding as of March 31, 2021.
|
2021-07-16 |
| 2021-08-05 | 3961.67 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Shares issued under stock option and employee stock purchase plans
|
2021-06-30 |
| 2021-05-06 | 3961.46 | 未披露 |
更多>>
from December 31, 2020 to March 31, 2021
Shares issued under stock option and employee stock purchase plans
|
2021-03-31 |
| 2021-03-29 | 3961.46 | 未披露 | 定期报告 | 2021-03-22 |
| 2021-03-29 | 3960.38 | 未披露 |
更多>>
from December 31, 2019 to December 31, 2020
Shares issued under stock option and employee stock purchase plans
Shares issued in connection with at the market agreement
Shares issued in underwritten public offering
|
2020-12-31 |
| 2020-11-06 | 3956.73 | 未披露 | 定期报告 | 2020-11-05 |
| 2020-11-05 | 3956.71 | 未披露 | 定期报告 | 2020-10-31 |
| 2020-11-05 | 3956.25 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
|
2020-09-30 |
| 2020-08-06 | 3912.64 | 未披露 | 定期报告 | 2020-07-31 |
| 2020-08-06 | 3909.39 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Shares Issued in Connection with Cantor Agreement
Shares Issued in Underwritten Offering
|
2020-06-30 |
| 2020-06-18 | 3593.32 | 未披露 |
更多>>
1.Common stock offered by us pursuant to this prospectus supplement 13,377,926 shares
2.The number of shares of common stock to be outstanding after this offering is based on 22,555,303 shares of common stock outstanding as of June 12, 2020
|
2020-06-18 |
| 2020-06-15 | 2255.53 | 未披露 | 定期报告 | 2020-06-12 |
| 2020-06-12 | 2067.53 | 未披露 | 定期报告 | 2020-06-10 |
| 2020-05-06 | 1893.81 | 未披露 | 定期报告 | 2020-04-30 |
| 2020-04-28 | 1808.21 | 未披露 | 定期报告 | 2020-04-21 |
| 2020-04-28 | 1785.76 | 未披露 | 定期报告 | 2020-04-08 |
| 2020-05-06 | 1773.08 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
|
2020-03-31 |
| 2020-03-26 | 1757.47 | 未披露 | 定期报告 | 2020-03-13 |
| 2020-03-26 | 1697.21 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
|
2019-12-31 |
| 2019-12-06 | 1671.32 | 未披露 | 定期报告 | 2019-12-04 |
| 2019-11-12 | 1613.01 | 未披露 | 定期报告 | 2019-10-31 |
| 2019-11-12 | 1590.45 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Shares Issued in Connection with Cantor Agreement
|
2019-09-30 |
| 2019-08-07 | 1501.86 | 未披露 | 定期报告 | 2019-07-31 |
| 2019-08-07 | 1481.69 | 未披露 |
更多>>
from March 31, 2019 to June 30,2019
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
|
2019-06-30 |
| 2019-05-07 | 1376.89 | 未披露 | 定期报告 | 2019-04-30 |
| 2019-04-26 | 1353.46 | 未披露 | 定期报告 | 2019-04-22 |
| 2019-04-26 | 1295.07 | 未披露 | 定期报告 | 2019-04-09 |
| 2019-05-07 | 1284.47 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
|
2019-03-31 |
| 2019-03-07 | 1243.97 | 未披露 | 定期报告 | 2019-02-28 |
| 2019-03-07 | 1195.76 | 未披露 |
更多>>
From December 31, 2017 to February 11, 2019
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
Shares Issued in Connection with Kolltan Severance
On February 8, 2019, Celldex Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Third Restated Certificate of Incorporation with the Secretary of State of the State of Delaware (the “Certificate of Amendment”), which effected, immediately upon filing, a one-for-fifteen reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding common stock, $0.001 par value per share (the “Common Stock”).As a result of the Reverse Stock Split, every fifteen shares of Common Stock issued and outstanding was converted into one share of Common Stock and the total number of shares of Common Stock outstanding will be reduced from approximately 181.8 million shares to approximately 12.1 million shares. No fractional shares were issued in connection with the Reverse Stock Split. Stockholders who would otherwise be entitled to a fractional share of Common Stock are instead entitled to receive a proportional cash payment.Trading of the Common Stock on a Reverse Stock Split-adjusted basis on the Nasdaq Capital Market will begin at the opening of trading on February 11, 2019
|
2019-02-11 |
| 2018-11-07 | 17246.56 | 未披露 | 定期报告 | 2018-10-31 |
| 2018-11-07 | 16857.55 | 未披露 | 定期报告 | 2018-09-30 |
| 2018-08-08 | 16244.23 | 未披露 | 定期报告 | 2018-07-31 |
| 2018-08-08 | 15664.59 | 未披露 | 定期报告 | 2018-06-30 |
| 2018-05-10 | 14339.28 | 未披露 | 定期报告 | 2018-05-03 |
| 2018-04-30 | 14338.73 | 未披露 | 定期报告 | 2018-04-10 |
| 2018-05-10 | 14336.88 | 未披露 | 定期报告 | 2018-03-31 |
| 2018-03-07 | 14107.37 | 未披露 | 定期报告 | 2018-02-28 |
| 2018-03-07 | 13852.04 | 未披露 |
更多>>
from December 31, 2016 to December 31, 2017
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
Shares Issued in Connection with Kolltan Severance
|
2017-12-31 |
| 2017-11-07 | 13598.53 | 未披露 | 定期报告 | 2017-10-31 |
| 2017-11-07 | 13210.85 | 未披露 | 定期报告 | 2017-09-30 |
| 2017-08-08 | 12834.18 | 未披露 | 定期报告 | 2017-07-31 |
| 2017-08-08 | 12741.20 | 未披露 | 定期报告 | 2017-06-30 |
| 2017-04-28 | 12510.47 | 未披露 | 定期报告 | 2017-04-10 |
| 2017-05-09 | 12417.37 | 未披露 | 定期报告 | 2017-03-31 |
| 2017-03-14 | 12321.34 | 未披露 | 定期报告 | 2017-03-06 |
| 2017-01-26 | 12227.84 | 未披露 | 定期报告 | 2017-01-24 |
| 2017-03-14 | 12051.67 | 未披露 |
更多>>
from December 31, 2015 to December 31, 2016
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
Shares Issued in Connection with the Kolltan Acquisition
Shares Issued in Connection with Kolltan Severance
|
2016-12-31 |
| 2016-11-07 | 10124.88 | 未披露 | 定期报告 | 2016-09-30 |
| 2016-08-08 | 10054.55 | 未披露 | 定期报告 | 2016-07-31 |
| 2016-08-08 | 9939.45 | 未披露 | 定期报告 | 2016-06-30 |
| 2016-05-05 | 9871.85 | 未披露 | 定期报告 | 2016-04-26 |
| 2016-05-05 | 9871.85 | 未披露 | 定期报告 | 2016-03-31 |
| 2016-02-23 | 9870.35 | 未披露 | 定期报告 | 2016-02-16 |
| 2016-02-23 | 9868.56 | 未披露 |
更多>>
from December 31, 2014 to December 31, 2015
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Underwritten Offering
|
2015-12-31 |
| 2015-11-05 | 9864.57 | 未披露 | 定期报告 | 2015-09-30 |
| 2015-08-10 | 9859.54 | 未披露 | 定期报告 | 2015-07-28 |
| 2015-08-10 | 9854.83 | 未披露 | 定期报告 | 2015-06-30 |
| 2015-04-23 | 9848.08 | 未披露 | 定期报告 | 2015-04-22 |
| 2015-04-29 | 9848.06 | 未披露 | 定期报告 | 2015-03-31 |
| 2015-02-24 | 8960.86 | 未披露 | 定期报告 | 2015-02-17 |
| 2015-02-24 | 8959.28 | 未披露 |
更多>>
from December 31, 2013 to December 31, 2014
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Supply Agreement
|
2014-12-31 |
| 2014-11-05 | 8958.91 | 未披露 | 定期报告 | 2014-10-31 |
| 2014-11-05 | 8943.69 | 未披露 | 定期报告 | 2014-09-30 |
| 2014-08-07 | 8940.38 | 未披露 | 定期报告 | 2014-07-28 |
| 2014-08-07 | 8939.62 | 未披露 | 定期报告 | 2014-06-30 |
| 2014-05-01 | 8935.78 | 未披露 | 定期报告 | 2014-03-31 |
| 2014-03-03 | 8925.17 | 未披露 | 定期报告 | 2014-02-19 |
| 2014-03-03 | 8924.68 | 未披露 |
更多>>
from December 31, 2012 to December 31, 2013
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
Shares Issued in Underwritten Offering
|
2013-12-31 |
| 2013-11-08 | 8110.82 | 未披露 | 定期报告 | 2013-10-29 |
| 2013-11-08 | 8110.81 | 未披露 | 定期报告 | 2013-09-30 |
| 2013-08-06 | 8098.79 | 未披露 | 定期报告 | 2013-07-29 |
| 2013-08-06 | 8097.77 | 未披露 | 定期报告 | 2013-06-30 |
| 2013-05-03 | 8087.03 | 未披露 | 定期报告 | 2013-03-31 |
| 2013-03-08 | 8059.93 | 未披露 | 定期报告 | 2013-02-28 |
| 2013-03-08 | 6435.95 | 未披露 |
更多>>
from December 31, 2011 to December 31, 2012
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
Shares Issued in Underwritten Offering
|
2012-12-31 |
| 2012-11-02 | 6197.51 | 未披露 | 定期报告 | 2012-10-30 |
| 2012-11-02 | 6080.74 | 未披露 | 定期报告 | 2012-09-30 |
| 2012-08-09 | 5929.21 | 未披露 | 定期报告 | 2012-07-31 |
| 2012-08-09 | 5875.36 | 未披露 | 定期报告 | 2012-06-30 |
| 2012-05-04 | 5873.56 | 未披露 | 定期报告 | 2012-03-31 |
| 2012-03-08 | 5716.06 | 未披露 | 定期报告 | 2012-02-29 |
| 2012-03-08 | 4421.06 | 未披露 |
更多>>
from December 31, 2010 to December 31, 2011
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
Shares Issued in Underwritten Offering
|
2011-12-31 |
| 2011-08-04 | 4414.72 | 未披露 | 定期报告 | 2011-06-30 |
| 2011-05-05 | 3255.54 | 未披露 | 定期报告 | 2011-04-28 |
| 2011-03-09 | 3205.54 | 未披露 |
更多>>
from December 31, 2009 to December 31, 2010
Shares Issued under Stock Option and Employee Stock Purchase Plans
|
2010-12-31 |
| 2010-11-04 | 3205.19 | 未披露 | 定期报告 | 2010-09-30 |
| 2010-08-05 | 3188.69 | 未披露 | 定期报告 | 2010-06-30 |
| 2010-05-06 | 3177.97 | 未披露 | 定期报告 | 2010-05-03 |
| 2010-05-06 | 3175.97 | 未披露 | 定期报告 | 2010-03-31 |
| 2010-05-12 | 3171.11 | 未披露 | 定期报告 | 2010-02-25 |
| 2010-03-12 | 3168.51 | 未披露 |
更多>>
from December 31, 2008 to December 31, 2009
Shares Issued in Connection with the CuraGen Merger
Shares Issued under Stock Option and Employee Stock Purchase Plans
|
2009-12-31 |
| 2009-03-02 | 1582.06 | 未披露 | 定期报告 | 2009-02-20 |
| 2009-03-02 | 2141.21 | 未披露 |
更多>>
from December 31, 2007 to December 31, 2008
Exchange of Class A for Common Stock
Shares Issued to Medarex in Settlement of a Payable
Shares Received in Exchange in the Merger
Shares Issued to Pfizer in connection with the CDX-110 Licensing Agreement
Shares Issued to Duke University in Settlement of a Payable
Reflect the one-for-twelve reverse stock split effected on March 7, 2008
|
2008-12-31 |
| 2008-03-18 | 1492.70 | 未披露 | 定期报告 | 2008-03-13 |
| 2008-03-18 | 618.23 | 未披露 |
更多>>
from December 31, 2006 to March 10, 2008
Employee Stock Purchase Plan Issuances
Reflect the one-for-twelve reverse stock split effected on March 7, 2008
|
2008-03-10 |
| 2007-03-16 | 7418.40 | 未披露 | 定期报告 | 2007-03-01 |
| 2007-03-16 | 7418.25 | 未披露 |
更多>>
from December 31, 2005 to December 31, 2006
Shares Issued upon Exercise of Stock Options
Employee Stock Purchase Plan Issuances
Reclassification of Deferred Compensation upon Adoption of FAS 123R
|
2006-12-31 |
| 2006-03-16 | 7417.27 | 未披露 | 定期报告 | 2006-03-01 |
| 2006-03-16 | 7416.68 | 未披露 |
更多>>
from December 31, 2004 to December 31, 2005
Shares Issued upon Exercise of Stock Options
Shares Issued upon Cashless Exercise of Warrants
Employee Stock Purchase Plan Issuances
Issuance of Restricted Stock Units
Amortization of Deferred Compensation
|
2005-12-31 |
| 2005-03-16 | 7413.28 | 未披露 | 定期报告 | 2005-03-01 |
| 2005-03-16 | 7413.13 | 未披露 |
更多>>
from December 31, 2003 to December 31, 2004
Shares Issued upon Exercise of Stock Options
Shares Issued upon Cashless Exercise of Warrants
Employee Stock Purchase Plan Issuance
Net Proceeds from Stock Issuance
|
2004-12-31 |
| 2004-03-15 | 7395.91 | 未披露 | 定期报告 | 2004-03-01 |
| 2004-03-15 | 6470.81 | 未披露 |
更多>>
from December 31, 2002 to December 31, 2003
Shares Issued upon Exercise of Stock Options
Shares Issued upon Cashless Exercise of Warrants
Employee Stock Purchase Plan Issuance
Net Proceeds from Stock Issuance
Issuance of Restricted Stock Units
Amortization of Deferred Compensation
|
2003-12-31 |
| 2003-03-25 | 6046.87 | 未披露 | 定期报告 | 2003-03-14 |
| 2003-03-25 | 6033.23 | 未披露 |
更多>>
from December 31, 2001 to December 31, 2002
Employee Stock Purchase Plan Issuance
Purchase of 132,600 Shares of Treasury Stock at Cost
|
2002-12-31 |
| 2002-03-29 | 6045.84 | 未披露 | 定期报告 | 2002-03-11 |
| 2002-03-29 | 6044.91 | 未披露 |
更多>>
from December 31, 2000 to December 31, 2001
Shares Issued upon Exercise of Stock Options
Shares Issued upon Exercise of Warrants
Employee Stock Purchase Plan Issuance
Net Proceeds from Stock Issuance
|
2001-12-31 |
| 2001-03-27 | 5728.55 | 未披露 | 定期报告 | 2001-03-01 |
| 2001-03-27 | 5714.42 | 未披露 |
更多>>
from DECEMBER 31, 1999 to DECEMBER 31, 2000
Shares Issued upon Exercise of Stock Options
Shares Issued upon Exercise of Warrants
Employee Stock Purchase Plan Issuance
Net Proceeds from Stock Issuance
Shares Issued for Acquisition of Megan Health, Inc
|
2000-12-31 |
| 2000-03-28 | 5001.28 | 未披露 | 定期报告 | 2000-03-10 |
| 2000-03-28 | 4812.74 | 未披露 |
更多>>
from DECEMBER 31, 1998 to DECEMBER 31, 1999
Issuance at $0.10 to $1.81 per Share upon Exercise of Stock Options
Employee Stock Purchase Plan Issuance at $1.46 to $1.78 per Share
Net Proceeds from Stock Issuance
|
1999-12-31 |
| 1999-03-25 | 4253.21 | 未披露 | 定期报告 | 1999-03-01 |
| 1999-03-25 | 4250.86 | 未披露 |
更多>>
from December 31, 1997 to December 31, 1998
Issuance at $0.60 to $1.81 per Share upon Exercise of Stock Options
Employee Stock Purchase Employee Stock Purchase $1.65 and $1.94 per Share
Returned Shares from Settlement of Litigation at $2.50 per Share
Net Proceeds from Stock Issuance
Acquisition of Virus Research Institute, Inc.
|
1998-12-31 |
| 1998-03-30 | 2647.89 | 未披露 | 定期报告 | 1998-03-02 |
| 1998-03-30 | 2647.77 | 未披露 |
更多>>
from December 31, 1996 to December 31, 1997
Issuance at $1.81 to $2.13 per Share upon Exercise of Stock Options
of Stock Options Settlement of Litigation
Compensation Expense Associated with Issuance at $1.94 per with Issuance at $1.94 per
Employee Stock Purchase Plan Issuance at $1.38 and $1.39 per Share
|
1997-12-31 |
| 1997-03-26 | 2494.66 | 未披露 |
更多>>
from December 31, 1995 to December 31, 1996
Issuance at $.60 to $3.56 per Share upon Exercise per Share upon Exercise
Net Proceeds from Stock Issuance
Employee Stock Purchase Plan Issuance at $2.71 per Share
|
1996-12-31 |
| 1996-04-01 | 1989.68 | 未披露 | 定期报告 | 1996-03-15 |
| 1996-04-01 | 1988.27 | 未披露 |
更多>>
from DECEMBER 31, 1994 to DECEMBER 31, 1995
Issuance at $.60 to $4.25 per Share upon Exercise of Stock Options
Private Placement Proceeds
Issuance at $1.65 upon Exercise of Stock Warrants
Purchase of 16,466 Shares of Treasury Stock at Cost
|
1995-12-31 |
| 1996-04-01 | 1703.79 | 未披露 |
更多>>
from DECEMBER 31, 1993 to DECEMBER 31, 1994
Issuance at $2.13 to $5.25 per Share upon Exercise per Share upon Exercise
Employee Stock Purchase Plan Issuance at $2.13 per Share
|
1994-12-31 |
From June 30, 2025 to September 30, 2025
Shares issued under stock option and employee stock purchase plans
From March 31, 2025 to June 30, 2025
Shares issued under stock option and employee stock purchase plans
From December 31, 2024 to March 31, 2025
Shares issued under stock option and employee stock purchase plans
From December 31, 2023 to December 31, 2024
Shares issued under stock option and employee stock purchase plans
Shares issued in underwritten offering, net
From June 30, 2024 to September 30, 2024
Shares issued under stock option and employee stock purchase plans
From March 31, 2024 to June 30, 2024
Shares issued under stock option and employee stock purchase plans
From December 31, 2023 to March 31, 2024
Shares issued under stock option and employee stock purchase plans
Shares issued in underwritten offering, net
Common stock offered 8,520,000 shares by the company
From December 31, 2022 to December 31, 2023
Shares issued in underwritten offering, net
Shares issued under stock option and employee stock purchase plans
Common stock offered 7,425,000 shares by the company
From June 30, 2023 to September 30, 2023
Shares issued under stock option and employee stock purchase plans
From December 31, 2022 to March 31, 2023
Shares issued under stock option and employee stock purchase plans
From December 31, 2021 to December 31, 2022
Shares issued under stock option and employee stock purchase plans
From June 30, 2022 to September 30, 2022
Shares issued under stock option and employee stock purchase plans
From March 31, 2022 to June 30, 2022
Shares issued under stock option and employee stock purchase plans
From December 31, 2021 to March 31, 2022
Shares issued under stock option and employee stock purchase plans
From December 31, 2020 to December 31, 2021
Shares issued under stock option and employee stock purchase plans
Shares issued in underwritten offering, net
From June 30, 2021 to September 30, 2021
Shares issued under stock option and employee stock purchase plans
Shares issued in underwritten offering, net
1.Common stock offered 5,952,381 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 39,614,638 shares of common stock outstanding as of March 31, 2021.
From March 31, 2021 to June 30, 2021
Shares issued under stock option and employee stock purchase plans
from December 31, 2020 to March 31, 2021
Shares issued under stock option and employee stock purchase plans
from December 31, 2019 to December 31, 2020
Shares issued under stock option and employee stock purchase plans
Shares issued in connection with at the market agreement
Shares issued in underwritten public offering
From June 30, 2020 to September 30, 2020
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
From March 31, 2020 to June 30, 2020
Shares Issued in Connection with Cantor Agreement
Shares Issued in Underwritten Offering
1.Common stock offered by us pursuant to this prospectus supplement 13,377,926 shares
2.The number of shares of common stock to be outstanding after this offering is based on 22,555,303 shares of common stock outstanding as of June 12, 2020
From December 31, 2019 to March 31, 2020
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
From December 31, 2018 to December 31, 2019
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
from June 30, 2019 to September 30, 2019
Shares Issued in Connection with Cantor Agreement
from March 31, 2019 to June 30,2019
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
from December 31, 2018 to March 31, 2019
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
From December 31, 2017 to February 11, 2019
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
Shares Issued in Connection with Kolltan Severance
On February 8, 2019, Celldex Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Third Restated Certificate of Incorporation with the Secretary of State of the State of Delaware (the “Certificate of Amendment”), which effected, immediately upon filing, a one-for-fifteen reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding common stock, $0.001 par value per share (the “Common Stock”).As a result of the Reverse Stock Split, every fifteen shares of Common Stock issued and outstanding was converted into one share of Common Stock and the total number of shares of Common Stock outstanding will be reduced from approximately 181.8 million shares to approximately 12.1 million shares. No fractional shares were issued in connection with the Reverse Stock Split. Stockholders who would otherwise be entitled to a fractional share of Common Stock are instead entitled to receive a proportional cash payment.Trading of the Common Stock on a Reverse Stock Split-adjusted basis on the Nasdaq Capital Market will begin at the opening of trading on February 11, 2019
from December 31, 2016 to December 31, 2017
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
Shares Issued in Connection with Kolltan Severance
from December 31, 2015 to December 31, 2016
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
Shares Issued in Connection with the Kolltan Acquisition
Shares Issued in Connection with Kolltan Severance
from December 31, 2014 to December 31, 2015
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Underwritten Offering
from December 31, 2013 to December 31, 2014
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Supply Agreement
from December 31, 2012 to December 31, 2013
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
Shares Issued in Underwritten Offering
from December 31, 2011 to December 31, 2012
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
Shares Issued in Underwritten Offering
from December 31, 2010 to December 31, 2011
Shares Issued under Stock Option and Employee Stock Purchase Plans
Shares Issued in Connection with Cantor Agreement
Shares Issued in Underwritten Offering
from December 31, 2009 to December 31, 2010
Shares Issued under Stock Option and Employee Stock Purchase Plans
from December 31, 2008 to December 31, 2009
Shares Issued in Connection with the CuraGen Merger
Shares Issued under Stock Option and Employee Stock Purchase Plans
from December 31, 2007 to December 31, 2008
Exchange of Class A for Common Stock
Shares Issued to Medarex in Settlement of a Payable
Shares Received in Exchange in the Merger
Shares Issued to Pfizer in connection with the CDX-110 Licensing Agreement
Shares Issued to Duke University in Settlement of a Payable
Reflect the one-for-twelve reverse stock split effected on March 7, 2008
from December 31, 2006 to March 10, 2008
Employee Stock Purchase Plan Issuances
Reflect the one-for-twelve reverse stock split effected on March 7, 2008
from December 31, 2005 to December 31, 2006
Shares Issued upon Exercise of Stock Options
Employee Stock Purchase Plan Issuances
Reclassification of Deferred Compensation upon Adoption of FAS 123R
from December 31, 2004 to December 31, 2005
Shares Issued upon Exercise of Stock Options
Shares Issued upon Cashless Exercise of Warrants
Employee Stock Purchase Plan Issuances
Issuance of Restricted Stock Units
Amortization of Deferred Compensation
from December 31, 2003 to December 31, 2004
Shares Issued upon Exercise of Stock Options
Shares Issued upon Cashless Exercise of Warrants
Employee Stock Purchase Plan Issuance
Net Proceeds from Stock Issuance
from December 31, 2002 to December 31, 2003
Shares Issued upon Exercise of Stock Options
Shares Issued upon Cashless Exercise of Warrants
Employee Stock Purchase Plan Issuance
Net Proceeds from Stock Issuance
Issuance of Restricted Stock Units
Amortization of Deferred Compensation
from December 31, 2001 to December 31, 2002
Employee Stock Purchase Plan Issuance
Purchase of 132,600 Shares of Treasury Stock at Cost
from December 31, 2000 to December 31, 2001
Shares Issued upon Exercise of Stock Options
Shares Issued upon Exercise of Warrants
Employee Stock Purchase Plan Issuance
Net Proceeds from Stock Issuance
from DECEMBER 31, 1999 to DECEMBER 31, 2000
Shares Issued upon Exercise of Stock Options
Shares Issued upon Exercise of Warrants
Employee Stock Purchase Plan Issuance
Net Proceeds from Stock Issuance
Shares Issued for Acquisition of Megan Health, Inc
from DECEMBER 31, 1998 to DECEMBER 31, 1999
Issuance at $0.10 to $1.81 per Share upon Exercise of Stock Options
Employee Stock Purchase Plan Issuance at $1.46 to $1.78 per Share
Net Proceeds from Stock Issuance
from December 31, 1997 to December 31, 1998
Issuance at $0.60 to $1.81 per Share upon Exercise of Stock Options
Employee Stock Purchase Employee Stock Purchase $1.65 and $1.94 per Share
Returned Shares from Settlement of Litigation at $2.50 per Share
Net Proceeds from Stock Issuance
Acquisition of Virus Research Institute, Inc.
from December 31, 1996 to December 31, 1997
Issuance at $1.81 to $2.13 per Share upon Exercise of Stock Options
of Stock Options Settlement of Litigation
Compensation Expense Associated with Issuance at $1.94 per with Issuance at $1.94 per
Employee Stock Purchase Plan Issuance at $1.38 and $1.39 per Share
from December 31, 1995 to December 31, 1996
Issuance at $.60 to $3.56 per Share upon Exercise per Share upon Exercise
Net Proceeds from Stock Issuance
Employee Stock Purchase Plan Issuance at $2.71 per Share
from DECEMBER 31, 1994 to DECEMBER 31, 1995
Issuance at $.60 to $4.25 per Share upon Exercise of Stock Options
Private Placement Proceeds
Issuance at $1.65 upon Exercise of Stock Warrants
Purchase of 16,466 Shares of Treasury Stock at Cost
from DECEMBER 31, 1993 to DECEMBER 31, 1994
Issuance at $2.13 to $5.25 per Share upon Exercise per Share upon Exercise
Employee Stock Purchase Plan Issuance at $2.13 per Share